Antibacterial activity of Rhodomyrtus tomentosa (Aiton) Hassk. Leaf extract against clinical isolates of streptococcus pyogenes

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Limsuwan, Surasak ^a   Kayser, Oliver ^b   Voravuthikunchai, Supayang Piyawan ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

^b TU DORTMUND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; ERYTHROMYCIN; PENICILLIN G; PLANT EXTRACT; RHODOMYRTUS TOMENTOSA EXTRACT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CELL MEMBRANE; CELL SURVIVAL; MEDICINAL PLANT; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; RHODOMYRTUS TOMENTOSA; STREPTOCOCCUS PYOGENES;

EID: 84866975205     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/697183     Document Type: Article

References (37)

1. Cunningham M. W., Pathogenesis of group a streptococcal infections. Clinical Microbiology Reviews 2000 13 3 470 511 2-s2.0-0033939735 10.1128/CMR.13.3.470-511.2000 (Pubitemid 30452618)
2. Bisno A. L., Gerber M. A., Gwaltney J. M., Kaplan E. L., Schwartz R. H., Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clinical Infectious Diseases 2002 35 2 113 125 2-s2.0-0037100250 10.1086/340949 (Pubitemid 34759916)
3. Pichichero M. E., Casey J. R., Mayes T., Francis A. B., Marsocci S. M., Murphy A. M., Hoeger W., Penicillin failure in streptococcal tonsillopharyngitis: causes and remedies. Pediatric Infectious Disease Journal 2000 19 9 917 923 2-s2.0-0033826360 10.1097/00006454-200009000-00035
4. Gastanaduy A. S., Huwe B. B., Kaplan E. L., Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. The Lancet 1980 2 8193 498 502 2-s2.0-0018952234
5. Smith T. D., Huskins W. C., Kim K. S., Kaplan E. L., Efficacy of β -lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis. The Journal of Pediatrics 1987 110 5 777 782 2-s2.0-0023195464 (Pubitemid 17074752)
6. Stromberg A., Schwan A., Cars O., Five versus ten days treatment of group A streptococcal pharyngotonsillitis: a randomized controlled clinical trial with phenoxymethylpenicillin and cefadroxil. Scandinavian Journal of Infectious Diseases 1988 20 1 37 46 2-s2.0-0023911291 (Pubitemid 18071709)
7. Roos K., Larsson P., Loracarbef versus phenoxymethylpenicillin in the treatment of recurrent streptococcal pharyngotonsillitis. Scandinavian Journal of Infectious Diseases 1997 29 2 141 145 2-s2.0-0030905626
8. Kaplan E. L., Johnson D. R., Unexplained reduced microbiological efficacy of intramuscular benzathine penicillin G and of oral penicillin V in eradication of group A streptococci from children with acute pharyngitis. Pediatrics 2001 108 5 1180 1186 2-s2.0-0034765377 10.1542/peds.108.5.1180 (Pubitemid 33021196)
9. Baker A. S., Behlau I., Tierney M. R., Gorbach S. L., Bartlett J. G., Blacklow N. R., Infections of the pharynx, larynx, epiglottis, trachea, and thyroid. Infectious Diseases. 1998 Philadelphia, Pa, USA W. B. Saunders Company 540 548
10. Stein G. E., Christensen S., Mummaw N., Comparative study of clarithromycin and penicillin V in the treatment of streptococcal pharyngitis. European Journal of Clinical Microbiology and Infectious Diseases 1991 10 11 949 953 2-s2.0-0026327519
11. Adam D., Scholz H., Aspe C., Berzel H. G., Bulle D., Fritz H. P., Grosse V., Hartmann W., Heil R. P., Hirschbrunn P., Hübschmann-Mehl U., Just J., Kielhorn A., Knauer B., Maurer L., Müller K., Niehaus G., Onken D., Raff W., Reineke J., Schulze-Buxloh A., Schumann D., Steiner M., Szdzuy C., Van Stiphout P., Weh M., Winter H., Wolff P., Zinke M., Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. European Journal of Clinical Microbiology and Infectious Diseases 1996 15 9 712 717 2-s2.0-10244242492 10.1007/BF01691957 (Pubitemid 26361393)
12. Feng L., Shen X., PP-011 High level macrolide resistant Streptococcus pyogenes Isolated from Chinese children and the relationship with Tn6002. International Journal of Infectious Diseases 2009 13 supplement 1 S53 10.1016/S1201-9712(09)60405-7
13. Gracia M., Díaz C., Coronel P., Gimeno M., García-Rodas R., Rodríguez-Cerrato V., del Prado G., Huelves L., Ruiz V., Naves P. F., Ponte M. C., Granizo J. J., Soriano F., Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program. Diagnostic Microbiology and Infectious Disease 2009 64 1 52 56 2-s2.0-65649143824
14. Michos A. G., Bakoula C. G., Braoudaki M., Koutouzi F. I., Roma E. S., Pangalis A., Nikolopoulou G., Kirikou E., Syriopoulou V. P., Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Diagnostic Microbiology and Infectious Disease 2009 64 3 295 299 2-s2.0-67349233039 10.1016/j.diagmicrobio.2009.03.004
15. Malli E., Tatsidou E., Damani A., Pantelidi K., Petinaki E., Skoulakis C., Drougka E., Spiliopoulou I., Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification. International Journal of Antimicrobial Agents 2010 35 6 614 615 2-s2.0-77951768899 10.1016/j.ijantimicag.2010.01.025
16. Bauer M. J., Georgousakis M. M., Vu T., Evaluation of novel Streptococcus pyogenes vaccine candidates incorporating multiple conserved sequences from the C-repeat region of the M-protein. Vaccine 2012 12 12 2197 2205
17. Zaman M., Abdel-Aal A. B., Fujita Y., Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship. PLoS ONE 2012 7 1 e30146
18. Limsuwan S., Trip E. N., Kouwen T. R. H. M., Piersma S., Hiranrat A., Mahabusarakam W., Voravuthikunchai S. P., van Dijl J. M., Kayser O., Rhodomyrtone: a new candidate as natural antibacterial drug from Rhodomyrtus tomentosa. Phytomedicine 2009 16 6-7 645 651 2-s2.0-67349154100 10.1016/j.phymed.2009.01.010
19. Hiranrat A., Mahabusarakam W., New acylphloroglucinols from the leaves of Rhodomyrtus tomentosa. Tetrahedron 2008 64 49 11193 11197 2-s2.0-54549084265 10.1016/j.tet.2008.09.054
20. Forbes B. A., Sahm D. F., Weissfeld A. S., Bailey & Scott's Diagnostic Microbiology 2002 St. Louis, Mo, USA Mosby
21. CLSI: Clinical and Laboratory Standards Institute, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Clinical and Laboratory Standards Institute Document M07-A8 2009 8th Wayne, Pa, USA Clinical and Laboratory Standards Institute
22. Chusri S., Voravuthikunchai S. P., Quercus infectoria: a candidate for the control of methicillin-resistant Staphylococcus aureus infections. Phytotherapy Research 2008 22 4 560 562 2-s2.0-42949085266 10.1002/ptr.2377 (Pubitemid 351613427)
23. Carson C. F., Mee B. J., Riley T. V., Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrobial Agents and Chemotherapy 2002 46 6 1914 1920 2-s2.0-0036096425 10.1128/AAC.46.6.1914-1920.2002 (Pubitemid 34535215)
24. Suwalak S., Voravuthikunchai S. P., Morphological and ultrastructural changes in the cell structure of enterohaemorrhagic Escherichia coli O157:H7 following treatment with Quercus infectoria nut galls. Journal of Electron Microscopy 2009 58 5 315 320 2-s2.0-70349451782 10.1093/jmicro/dfp024
25. Pichichero M. E., Casey J. R., Systematic review of factors contributing to penicillin treatment failure in Streptococcus pyogenes pharyngitis. Otolaryngology 2007 137 6 851 857 2-s2.0-36148972031 10.1016/j.otohns.2007.07. 033 (Pubitemid 350117062)
26. Limsuwan S., Subhadhirasakul S., Voravuthikunchai S. P., Medicinal plants with significant activity against important pathogenic bacteria. Pharmaceutical Biology 2009 47 8 683 689 2-s2.0-77149169145 10.1080/13880200902930415
27. Horne D., Holm M., Oberg C., Chao S., Young D. G., Antimicrobial effects of essential oils on Streptococcus pneumoniae. Journal of Essential Oil Research 2001 13 5 387 392 2-s2.0-0034769017 (Pubitemid 32992977)
28. Oonmetta-aree J., Suzuki T., Gasaluck P., Eumkeb G., Antimicrobial properties and action of galangal (Alpinia galanga Linn.) on Staphylococcus aureus. LWT-Food Science and Technology 2006 39 10 1214 1220 2-s2.0-33745183564 10.1016/j.lwt.2005.06.015
29. Hugo W. B., Longworth A. R., Some aspects of the mode of action of chlorhexidine. The Journal of Pharmacy and Pharmacology 1964 16 10 655 662 2-s2.0-78651152530
30. Joswick H. L., Corner T. R., Silvernale J. N., Gerhardt P., Antimicrobial actions of hexachlorophene: release of cytoplasmic materials. Journal of Bacteriology 1971 108 1 492 500 2-s2.0-0015130214
31. Silver S., Wendt L., Mechanism of action of phenethyl alcohol: breakdown of the cellular permeability barrier. Journal of Bacteriology 1967 93 2 560 566 2-s2.0-0014056267
32. Onawunmi G. O., In vitro studies on the antibacterial activity of phenoxyethanol in combination with lemon grass oil. Pharmazie 1988 43 1 42 44 2-s2.0-0023835607 (Pubitemid 18035216)
33. Ifesan B. O. T., Joycharat N., Voravuthikunchai S. P., The mode of antistaphylococcal action of Eleutherine americana. FEMS Immunology and Medical Microbiology 2009 57 2 193 201 2-s2.0-70349663936 10.1111/j.1574-695X.2009. 00599.x
34. Saising J., Hiranrat A., Mahabusarakam W., Ongsakul M., Voravuthikunchai S. P., Rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. as a natural antibiotic for staphylococcal cutaneous infections. Journal of Health Science 2008 54 5 589 595 2-s2.0-54249141696 10.1248/jhs.54.589
35. Limsuwan S., Hesseling-Meinders A., Voravuthikunchai S. P., van Dijl J. M., Kayser O., Potential antibiotic and anti-infective effects of rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. on Streptococcus pyogenes as revealed by proteomics. Phytomedicine 2011 18 11 934 940 2-s2.0-79952848734 10.1016/j.phymed.2011.02.007
36. Sianglum W., Srimanote P., Wonglumsom W., Kittiniyom K., Voravuthikunchai S. P., Proteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate. PLoS ONE 2011 6 2 2-s2.0-79951529993 10.1371/journal.pone.0016628 e16628
37. Visutthi M., Srimanote P., Voravuthikunchai S. P., Responses in the expression of extracellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone. The Journal of Microbiology 2011 49 6 956 964